Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.

The burden of STIs is particularly high in HIV-infected MSM patients. A recent increase in STIs prevalence has been noticed in the US and western European countries. We aim to assess trends in asymptomatic STIs following the publication of recommendations for STIs screening, i.e. Chlamydia (CT) and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Eric Farfour, Svetlane Dimi, Olivier Chassany, Sébastien Fouéré, Nadia Valin, Julie Timsit, Jade Ghosn, Claudine Duvivier, Martin Duracinsky, David Zucman, DRIVER study group
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7bff8603954d4a939f099c4509d5077c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7bff8603954d4a939f099c4509d5077c
record_format dspace
spelling oai:doaj.org-article:7bff8603954d4a939f099c4509d5077c2021-12-02T20:05:18ZTrends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.1932-620310.1371/journal.pone.0250557https://doaj.org/article/7bff8603954d4a939f099c4509d5077c2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0250557https://doaj.org/toc/1932-6203The burden of STIs is particularly high in HIV-infected MSM patients. A recent increase in STIs prevalence has been noticed in the US and western European countries. We aim to assess trends in asymptomatic STIs following the publication of recommendations for STIs screening, i.e. Chlamydia (CT) and gonorrhea (NG). Seventeen centers located in the Paris area participated in the study. All asymptomatic HIV-infected MSM patients attending a follow up consultation were proposed to participated in the study. Asymptomatic patients were included over 2 periods: period 1 from April to December 2015 and period 2 from September to December 2017. Etiologic diagnosis of STIs including hepatitis B, C, syphilis, was performed using a serological test, including a non-treponemal titer with a confirmatory treponemal assay for syphilis. CT and NG were screened using a nucleic acid amplification test (NAATs) on 3 anatomical sites, i.e. urine, rectal and pharyngeal. Overall, 781 patients were included: 490 and 291 in periods 1 and 2 respectively. Asymptomatic CT, NG, and syphilis were diagnosed in 7.5%, 4.8% and, 4.2% respectively. The rate of patients having a multisite asymptomatic infection was 10.2% and 21.1% for CT and NG respectively. The most frequently involved anatomical sites for CT and NG asymptomatic infections were anorectal (66.1% and 55.2% respectively) and pharyngeal (47.4% and 60.5% respectively). CT and NG asymptomatic infection increased by 1.3- and 2-fold respectively between the two periods while syphilis decreased by 3 folds. Our results encourage to reconsider multisite screening for CT and NG in asymptomatic HIV positive MSM as the yield of screening urinary samples only might be low. Despite the more systematic STI screening of asymptomatic HIV positive MSM the prevalence of STI is increasing in MSM in France. Therefore, this strategy has not led to alter CT and NG transmission. The decrease of syphilis might involve self-medication by doxycycline, and the intensification of syphilis screening.Eric FarfourSvetlane DimiOlivier ChassanySébastien FouéréNadia ValinJulie TimsitJade GhosnClaudine DuvivierMartin DuracinskyDavid ZucmanDRIVER study groupPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 6, p e0250557 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Eric Farfour
Svetlane Dimi
Olivier Chassany
Sébastien Fouéré
Nadia Valin
Julie Timsit
Jade Ghosn
Claudine Duvivier
Martin Duracinsky
David Zucman
DRIVER study group
Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.
description The burden of STIs is particularly high in HIV-infected MSM patients. A recent increase in STIs prevalence has been noticed in the US and western European countries. We aim to assess trends in asymptomatic STIs following the publication of recommendations for STIs screening, i.e. Chlamydia (CT) and gonorrhea (NG). Seventeen centers located in the Paris area participated in the study. All asymptomatic HIV-infected MSM patients attending a follow up consultation were proposed to participated in the study. Asymptomatic patients were included over 2 periods: period 1 from April to December 2015 and period 2 from September to December 2017. Etiologic diagnosis of STIs including hepatitis B, C, syphilis, was performed using a serological test, including a non-treponemal titer with a confirmatory treponemal assay for syphilis. CT and NG were screened using a nucleic acid amplification test (NAATs) on 3 anatomical sites, i.e. urine, rectal and pharyngeal. Overall, 781 patients were included: 490 and 291 in periods 1 and 2 respectively. Asymptomatic CT, NG, and syphilis were diagnosed in 7.5%, 4.8% and, 4.2% respectively. The rate of patients having a multisite asymptomatic infection was 10.2% and 21.1% for CT and NG respectively. The most frequently involved anatomical sites for CT and NG asymptomatic infections were anorectal (66.1% and 55.2% respectively) and pharyngeal (47.4% and 60.5% respectively). CT and NG asymptomatic infection increased by 1.3- and 2-fold respectively between the two periods while syphilis decreased by 3 folds. Our results encourage to reconsider multisite screening for CT and NG in asymptomatic HIV positive MSM as the yield of screening urinary samples only might be low. Despite the more systematic STI screening of asymptomatic HIV positive MSM the prevalence of STI is increasing in MSM in France. Therefore, this strategy has not led to alter CT and NG transmission. The decrease of syphilis might involve self-medication by doxycycline, and the intensification of syphilis screening.
format article
author Eric Farfour
Svetlane Dimi
Olivier Chassany
Sébastien Fouéré
Nadia Valin
Julie Timsit
Jade Ghosn
Claudine Duvivier
Martin Duracinsky
David Zucman
DRIVER study group
author_facet Eric Farfour
Svetlane Dimi
Olivier Chassany
Sébastien Fouéré
Nadia Valin
Julie Timsit
Jade Ghosn
Claudine Duvivier
Martin Duracinsky
David Zucman
DRIVER study group
author_sort Eric Farfour
title Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.
title_short Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.
title_full Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.
title_fullStr Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.
title_full_unstemmed Trends in asymptomatic STI among HIV-positive MSM and lessons for systematic screening.
title_sort trends in asymptomatic sti among hiv-positive msm and lessons for systematic screening.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/7bff8603954d4a939f099c4509d5077c
work_keys_str_mv AT ericfarfour trendsinasymptomaticstiamonghivpositivemsmandlessonsforsystematicscreening
AT svetlanedimi trendsinasymptomaticstiamonghivpositivemsmandlessonsforsystematicscreening
AT olivierchassany trendsinasymptomaticstiamonghivpositivemsmandlessonsforsystematicscreening
AT sebastienfouere trendsinasymptomaticstiamonghivpositivemsmandlessonsforsystematicscreening
AT nadiavalin trendsinasymptomaticstiamonghivpositivemsmandlessonsforsystematicscreening
AT julietimsit trendsinasymptomaticstiamonghivpositivemsmandlessonsforsystematicscreening
AT jadeghosn trendsinasymptomaticstiamonghivpositivemsmandlessonsforsystematicscreening
AT claudineduvivier trendsinasymptomaticstiamonghivpositivemsmandlessonsforsystematicscreening
AT martinduracinsky trendsinasymptomaticstiamonghivpositivemsmandlessonsforsystematicscreening
AT davidzucman trendsinasymptomaticstiamonghivpositivemsmandlessonsforsystematicscreening
AT driverstudygroup trendsinasymptomaticstiamonghivpositivemsmandlessonsforsystematicscreening
_version_ 1718375490491777024